Two Sigma Investments’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
Other funds holding DYN
Two Sigma Investments's DYN Position: Q3 2026 in Review
Two Sigma Investments increased its Dyne Therapeutics (DYN) stake by 375% in Q3 2026, buying an estimated $1.22M and bringing the position to 67,398 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #3516.
Two Sigma Investments first reported a position in DYN in Q1 2021 and has held it in 13 quarters since. The position peaked at $5.62M in Q2 2024. 270 funds tracked by Wall St. Rank hold DYN as of Q3 2026.
- Two Sigma Investments held 67,398 shares of Dyne Therapeutics worth $1.09M as of Q3 2026.
- Two Sigma Investments bought 53,220 Dyne Therapeutics shares in Q3 2026, an estimated $1.22M.
- Dyne Therapeutics made up ﹤0.01% of Two Sigma Investments's portfolio in Q3 2026, its #3516 holding.
- Two Sigma Investments first reported a position in Dyne Therapeutics in Q1 2021 and has held it in 13 quarters since.
- Two Sigma Investments's Dyne Therapeutics position peaked at $5.62M in Q2 2024.
- 270 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2026.
Based on Two Sigma Investments's 13F filing for Q3 2026, filed 16 Nov 2026.